论文部分内容阅读
目的探讨黄芪颗粒治疗小儿反复呼吸道感染(recurrent respiratory tract infections,RRTIs)的效果。方法选择2011年1—12月收治的RRTIs患儿98例,随机分为治疗组50例和对照组48例。两组均予以常规抗感染对症治疗,治疗组给予黄芪颗粒(15 g/袋)口服,6个月~3岁每次1/2袋,3~6岁每次2/3袋,6~12岁每次1袋,2次/d,用温开水冲服。两组均治疗3个月比较疗效。计量资料采用t检验,计数资料采用χ2检验,P<0.05为差异有统计学意义。结果总有效率治疗组86.0%,对照组58.3%,两组比较差异有统计学意义(χ2=9.391,P<0.05)。结论黄芪颗粒治疗小儿RRTIs效果显著,安全性高,且口感较好,价格相对低廉,患儿及家长易接受,值得临床推广。
Objective To investigate the effect of Astragalus Granules on recurrent respiratory tract infections (RRTIs) in children. Methods A total of 98 children with RRTIs admitted from January to December in 2011 were randomly divided into treatment group (n = 50) and control group (n = 48). Both groups were treated with conventional anti-infective symptomatic treatment, the treatment group given Astragalus Granules (15 g / bag) orally, 6 months to 3 years old each 1/2 bag, 3 to 6 years old every 2/3 bags, 6-12 1 bag each year, 2 times / d, with warm boiled water. Two groups were treated for 3 months more effective. Measurement data using t test, count data using χ2 test, P <0.05 for the difference was statistically significant. Results The total effective rate was 86.0% in the treatment group and 58.3% in the control group, with significant difference between the two groups (χ2 = 9.391, P <0.05). Conclusion Astragalus Granules treatment of children with RRTIs significant effect, high safety, and taste better, the price is relatively low, children and parents easily accepted, worthy of clinical promotion.